HUGHES-WILSON ALEXANDRA (See Remarks) sold 74.6% of their position (148.11K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $637.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
American Depositary Shares representing Ordinary Shares
Shares
−7.77K
Price / share
$4.47
Trade value
$34.75K
% of position
American Depositary Shares representing Ordinary Shares
Shares
−40.03K
Price / share
$4.47
Trade value
$179.04K
% of position
American Depositary Shares representing Ordinary Shares
Shares
−16.30K
Price / share
$4.22
Trade value
$68.82K
% of position
American Depositary Shares representing Ordinary Shares
Shares
−84.01K
Price / share
$4.22
Trade value
$354.60K
% of position
Net shares
−148.11K
Net value
-$637.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −7.77K | $4.47 | $34.75K | 3.9% | 198.59K | 190.82K |
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −40.03K | $4.47 | $179.04K | 21.0% | 190.82K | 150.79K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −16.30K | $4.22 | $68.82K | 10.8% | 150.79K | 134.48K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −84.01K | $4.22 | $354.60K | 62.5% | 134.48K | 50.48K |
| Total | −148.11K | -$637.20K | ||||||